Oct
2026
Fiera Milano, Italy
Visit us
stand 4F17, API

Fosun Wanbang (Jiangsu) Pharmaceutical Group Co.,Ltd.

Exhibitor at CPHI Milan 2026
About Us

Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd. is a global innovation-driven pharmaceutical company in China, and is a core member enterprise of Fosun Pharma. Business covers the whole healthcare industry chain including pharmaceutical R&D, manufacturing, wholesale and distribution. Several production lines have passed FDA /EU site audits.  Key products include Human Insulins and GLP-1 products, EPO, and Heparin Sodium, OSD products such as Ticagrelor Tabs, Tofacitinib Tabs, Crizotinib Caps and Osimertinib Tabs.  Key APIs includes Insulins, Heparin Sodium, Venetoclax and Febuxostat

  • Country/Region:
    China
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    5000+
Company types
Manufacturer/Innovator
Primary activities
API Producer
Biopharmaceutical
Contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 4F17, API

Products Featured at CPHI Milan 2026

  • Lei Wan Capsules

    Product Lei Wan Capsules

    Wanbang Biopharmaceuticals offers a wide range of cardiovascular product which includes lei wan capsules. Dosage Form: capsule 0.3 / tablets. It is huatanruanjianpian and used for the adjuvant treatment of cancer. Contact us for more information.
  • Apixaban Tablets

    Product Apixaban Tablets

    China & USA under registration
  • Compound Aloe Capsules

    Product Compound Aloe Capsules

    For hyperactivity of heart-liver heat, constipation, abdomina distension
  • Crizotinib Capsules